Date:
August 2025

Issue:
308

File Type:
PDF

View the PDF

Includes: Navigating Sexual Relationships After Cancer, 50/50 Raffle at $180, Urgent Need of a
Vice President, ,Scientists uncover immune cells that help prostate cancer resist treatment—and reveal a way to stop them, Enzalutamide Prolongs Survival in nmHSPC With Biochemical Recurrence, Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published, Focal Therapy Finding Its Niche for Intermediate-Risk Prostate Cancer, Study shows favorable outcomes with guideline-based treatment for localized prostate cancer, Carotuximab/Apalutamide Shows Tolerability in Metastatic CRPC, NeuroSafe Technique for Radical Prostatectomy Protects Potency, Continence in Trial, Exosomes: A Promising Tool for Liquid Biopsy in Prostate Cancer, Why some men experience urinary leaks—or incontinence, Mindfulness, Tai Chi Improve Wellbeing in Distressed Cancer Survivors, Student designs prostate screening device to replace traditional examination method, FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI, Researchers Gain New Insight Into Long-Term Effects of Chemotherapy, Low-intensity shockwave therapy for erectile dysfunction, A new way to treat cancer: Targeting the Hedgehog protein’s hidden weakness, Cellular signature explains why some prostate tumors resist standard treatments, AI-based tool can ‘measure’ cancer aggressiveness and paves the way for new therapies, and more.

Leave a Reply

Your email address will not be published. Required fields are marked *